English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
News and events


10 September 2019 - World Drug Safety Congress Europe, 10-11 September 2019, Amsterdam

Invited speaker: Margherita D’Antuono, Corporate Pharmacovigilance Director, EU QPPV Italfarmaco S.p.A.

07 September 2019 - Bring your light for the World Duchenne Awareness Day

Italfarmaco is devoted to bring the light of hope into the world of Duchenne by committing to develop drugs to slow down the disease progression...

06 June 2019 - Award Ceremony of Le Fonti Awards, June 6th 2019

Award obtained:
Italfarmaco, Excellence of the Year Innovation & Leadership R&D Pharmaceutical Sector for being an Italian excellence in the pharmaceutical sector.

29 March 2019 - Italfarmaco Group is pleased to announce the marketing of GhemaXan, the first biosimilar of Enoxaparin Sodium developed and produced in Italy

25 February 2019 - Italfarmaco launches NUPERAL in Italy, the first drug as fixed combination of doxilamine succinate and pyridoxine hydrochloride authorized for the symptomatic treatment of nausea and vomiting during pregnancy

20 February 2019 - Gordon Research Conference on Cancer Genetics and Epigenetics

31 January 2019 - Italfarmaco strengthen its presence in rare disease area by launching the medicinal product VOTUBIA

09 November 2018 - TRiNDS and Italfarmaco Announce US Patient Advocacy Partnership for EPIDYS Trial of Givinostat for Duchenne Muscular Dystrophy

26 September 2018 - New Marketing launch of SONIDOR, a food supplement based on hawthorn, lavender and hops extracts that induce sleep and relaxation